Pharma industry is discretely working against a global tax agreement
The pharmaceutical industry is fighting against a threat to companies' bottom lines: a global agreement which will harmonize corporation tax.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
The Wall Street Journal reports that pharmaceutical companies are asking that the industry should not be taxed further, reasoning that it has created vaccines against the covid-19 virus.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA gives Saniona candidate priority status
For subscribers
US sees global tax agreement as beneficial for all
For subscribers
Biden starts new offensive to bring down medicine prices
For subscribers
